Session title: Exploring Ethical, Equity, and Regulatory Implications for Pharmacogenomics in Psychiatric Care Settings
Duke Margolis Institute for Health Policy and CERA Collaboration
Session title: Exploring Ethical, Equity, and Regulatory Implications for Pharmacogenomics in Psychiatric Care Settings
Duke Margolis Institute for Health Policy and CERA Collaboration
Session title: An Overview of Pharmacogenomic Testing (PGx) from an ELSI, Psychology, and Psychiatry Perspective
Duke Margolis Institute for Health Policy and CERA Collaboration
A pre- and post-test questionnaire that measures changes in the knowledge and attitudes of physicians who have been administered pharmacogenetic testing is available in the supporting information section of the linked publication in both English and Korean. The survey includes items for demographic information, clinical history, attitudes towards adverse drug reactions, experience with clinical genomics, attitudes toward and experience with pharmacogenomics, price expectations for pharmacogenomics testing, and interpretation of the value of the pharmacogenomics report.